IN 2022, Hong Kong-based pharma company Insilico Medicine along with researchers from Stanford University, US, and the University of Toronto, Canada, began a unique experiment, powered by three artificial intelligence (AI)tools.
The experiment was to find a cure for Hepatocellular carcinoma, the most common form of liver cancer. In the first stage, the company's biocomputational platform called PandaOmics scanned through endless research papers online to shortlist 20 potential targets-either proteins or enzymes for drugs to act on. Of these, the researchers selected cyclin-dependent kinase 20 (CDK20)-an enzyme that had topped the list. In the second stage, the researchers turned to AlphaFold, a Google-owned open access AI system that predicts a protein's (all enzymes are proteins) three-dimensional (3D) structure. Of the 20,000 proteins present in the human body, structures for only 10 per cent are known, and CDK20 was one of the unknowns. Knowing the protein's shape is necessary to find chemicals capable of binding and inactivating it. Finally, the researchers fed the 3D structure into Chemistry42, an AI algorithm owned by Insilco Medicine, which designed 8,918 new chemicals with a high probability of attaching to CDK20. The researchers used computational modelling to virtually fit the chemicals with CDK20 and shortlisted seven candidates showing the best affinity for the target. They then constructed physical tests to assess how strongly the seven candidates attached to the enzyme and picked the chemical showing the best affinity.
The entire process took just 30 days. It would have taken at least six months (even a year) if all 8,918 chemicals were tested individually. The results are published in January 2023 in the journal Chemical Science.
This story is from the April 01, 2023 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 01, 2023 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
THE ALCHEMY OF EMOTIONS - SL'OTH
As with all personality traits, laziness is a combination of genes and environment
THE AL'CHEMY OF EMOTIONS - WRATH
Anger is an emotional programme, a part of natural selection that helps us bargain for better treatment
THE AL'CHEMY OF EMOTIONS - GLUTTONY
We have been captured by food and it is driving us to do something that is arguably not good for us
THE AL'CHEMY OF EMOTIONS - ENVY
Envy gives people a fundamental desire for a higher social rank
THE AL'CHEMY OF EMOTIONS-L'UST
Love, lust, attachments are basic brain circuits. They are too primitive a system and will never change
THE AL'CHEMY OF EMOTIONS - GREED
Evolutionary biology sees greed as a way to increase your chances of survival
THE AL'CHEMY OF EMOTIONS
I felt for the tormented whirlwinds Damned for their carnal sins Committed when they let their passions rule their reason
INVISIBLE THREAT
Significant presence of microplastics in Puducherry’s agricultural soil raises concerns for soil and crop health
Feeding off each other
VEGETARIAN MOVEMENTS IN SOUTH ASIA AND THE WEST GREW WITH MUTUAL SUPPORT AND VALIDATION
India's unhealthy patent amendments
Despite strong pleas, the Modi regime has changed the rules to impose a cost on those who challenge faulty patents